SHAPERON INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,105 KRW | +9.86% |
|
+5.30% | -44.02% |
| 03-18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
| 2022 | Shaperon Inc. has completed an IPO in the amount of KRW 13.735 billion. | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 159,514 | 86,747 |
| Enterprise Value (EV) 1 | 127,934 | 67,207 |
| P/E ratio | -13.3 x | -6.96 x |
| Yield | - | - |
| Capitalization / Revenue | 79.8 x | 403 x |
| EV / Revenue | 64 x | 312 x |
| EV / EBITDA | -12.2 x | -5.4 x |
| EV / FCF | - | -6,965,831 x |
| FCF Yield | - | -0% |
| Price to Book | 5.45 x | 4.57 x |
| Nbr of stocks (in thousands) | 22,467 | 23,071 |
| Reference price 2 | 7,100 | 3,760 |
| Announcement Date | 21/03/24 | 21/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Net sales 1 | 2,000 | 215.3 |
| EBITDA 1 | -10,491 | -12,441 |
| EBIT 1 | -11,030 | -13,228 |
| Operating Margin | -551.5% | -6,145.52% |
| Earnings before Tax (EBT) 1 | -10,683 | -12,388 |
| Net income 1 | -10,673 | -12,403 |
| Net margin | -533.64% | -5,762.3% |
| EPS 2 | -532.0 | -540.6 |
| Free Cash Flow | - | -9,648 |
| FCF margin | - | -4,482.22% |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 21/03/24 | 21/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Net Debt 1 | - | - |
| Net Cash position 1 | 31,580 | 19,540 |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | -9,648 |
| ROE (net income / shareholders' equity) | - | -51.4% |
| ROA (Net income/ Total Assets) | - | -27.5% |
| Assets 1 | - | 45,127 |
| Book Value Per Share 2 | 1,303 | 823.0 |
| Cash Flow per Share 2 | 193.0 | 280.0 |
| Capex 1 | 187 | 1,907 |
| Capex / Sales | 9.36% | 885.95% |
| Announcement Date | 21/03/24 | 21/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -44.02% | 35.09M | |
| +18.15% | 124B | |
| +18.02% | 112B | |
| +5.07% | 22.94B | |
| -12.75% | 22.22B | |
| -9.86% | 17.02B | |
| -14.97% | 16.88B | |
| -39.94% | 16.87B | |
| +2.80% | 13.63B | |
| +27.39% | 11.61B |
- Stock Market
- Equities
- A378800 Stock
- Financials Shaperon Inc.